This lecture will review the management of lacrimal gland tumors, epithelial and lymphoproliferative, by looking at natural history, imaging characteristics and treatment modalities. We will discuss the improved survival and ability to preserve the eye with current treatment modalities including a combination approach of surgery and adjuvant radiation. Furthermore, we will review the evidence for ultra low dose radiation for MALT lymphoma of the lacrimal gland. Lastly, we will discuss possible future direction in using genetic mutation profile to guide management of epithelial tumor of the lacrimal gland.
Lecturer: Dr. Vivian Yin, Memorial Sloan Kettering Cancer Center, New York, USA